Ravelcare FY26 net profit rises 1.3% to ₹515.40 crore
Ravelcare Limited reported a 1.3% rise in net profit to ₹515.40 crore for FY26, with revenue from operations increasing to ₹2695.43 crore. The board approved the audited financial results and re-appointed internal auditors M/s. Mahesh Dhabalia & Co. for FY 2026-27.

*this image is generated using AI for illustrative purposes only.
Ravelcare Limited reported a net profit of ₹515.40 crore for the financial year ended March 31, 2026, representing a 1.3% increase compared to ₹508.56 crore in the previous year. Revenue from operations for the year stood at ₹2695.43 crore, up from ₹2497.89 crore in FY25. The board approved the audited financial results for the half year and full year ended March 31, 2026, at a meeting held on May 30, 2026.
The statutory auditors issued an audit report with an unmodified opinion on the financial results for the year ended March 31, 2026. For the half year ended March 31, 2026, the company reported a net profit of ₹195.13 crore, while revenue from operations was ₹1255.67 crore. Total income for the full year rose to ₹2703.71 crore from ₹2529.80 crore in the prior year.
The board also approved the re-appointment of M/s. Mahesh Dhabalia & Co., Chartered Accountants, as internal auditors for the financial year 2026-27. The re-appointment is effective from May 30, 2026. The meeting commenced at 8:00 p.m. and concluded at 8:30 p.m.
Financial Results Summary
| Particulars | Year Ended 31/03/2026 (₹ In Lakh) | Year Ended 31/03/2025 (₹ In Lakh) |
|---|---|---|
| Revenue from Operations | 2695.43 | 2497.89 |
| Total Income | 2703.71 | 2529.80 |
| Total Expenses | 1996.46 | 1826.44 |
| Profit Before Tax | 707.25 | 703.36 |
| Net Profit | 515.40 | 508.56 |
| Basic EPS (₹) | 9.20 | 10.16 |
The trading window for dealing in the shares of Ravelcare Limited, which was closed since April 01, 2026, will reopen 48 hours after the conclusion of the board meeting.
Historical Stock Returns for Ravelcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.23% | -26.84% | -33.32% | -32.97% | -32.97% | -32.97% |
What strategic initiatives will Ravelcare undertake to improve profit margins given the modest 1.3% profit growth compared to revenue expansion?
How does the company plan to address the decline in Basic EPS from ₹10.16 to ₹9.20 despite the increase in net profit?
What are the management's revenue and profitability targets for the upcoming fiscal year 2026-27?


























